Follow
Jote Bulcha
Title
Cited by
Cited by
Year
Viral vector platforms within the gene therapy landscape
JT Bulcha, Y Wang, H Ma, PWL Tai, G Gao
Signal transduction and targeted therapy 6 (1), 53, 2021
7692021
A persistence detector for metabolic network rewiring in an animal
JT Bulcha, GE Giese, MZ Ali, YU Lee, MD Walker, AD Holdorf, LS Yilmaz, ...
Cell reports 26 (2), 460-468. e4, 2019
442019
High seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers
T Gelanew, B Seyoum, A Mulu, A Mihret, M Abebe, L Wassie, B Gelaw, ...
BMC Infectious Diseases 22 (1), 261, 2022
322022
Specificity versus redundancy in the RAP2.4 transcription factor family of Arabidopsis thaliana: transcriptional regulation of genes for chloroplast peroxidases
R Rudnik, JT Bulcha, E Reifschneider, U Ellersiek, M Baier
BMC plant biology 17, 1-17, 2017
272017
Signal Transduct
JT Bulcha, Y Wang, H Ma, PWL Tai, G Gao
Target. Ther 6 (53), 1, 2021
142021
Identification and characterization of ERFIb transcription factor binding motifs and their target genes
JT Bulcha
12013
Aav production strategy using a cell line expressing an inducible rep gene
G Gao, D Wang, J Bulcha
US Patent App. 17/767,962, 2023
2023
High Seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers [preprint]
T Gelanew, JT Bulcha, FG Tafesse, A Abdissa
2021
High Seroprevalence of Anti-SARS-CoV-2 Antibodies Among Ethiopian Healthcare Workers (preprint)
B Seyoum, A Mulu, A Mihret, M Abebe, L Wassie, B Gelaw, A Sorsa, ...
2021
A Persistence Detector for Metabolic Network Rewiring in an Animal [preprint]
JT Bulcha, GE Giese, Z Ali, YU Lee, MD Walker, AD Holdorf, LS Yilmaz, ...
2018
High Seroprevalence of Anti-SARS-CoV-2 Antibodies Among Ethiopian Healthcare Workers
B Seyoum, A Mulu, A Mihret, M Abebe, L Wassie, B Gelaw, A Sorsa, ...
The system can't perform the operation now. Try again later.
Articles 1–11